BlueHealer Inc. — SEC Form D Filing

BlueHealer Inc. filed an SEC Form D on November 4, 2026, reporting $1 raised in Biotechnology.

Form D filing details

Filing
SEC Form D
Filing date
November 4, 2026
Amount reported
$1
Round stage
Pre-seed, as BlueHealer was incorporated in 2024 and has relied primarily on initial non-dilutive grant funding alongside a nominal equity filing.
Industry
Biotechnology
Website
https://www.bluehealer.com

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Patients suffering from severe peripheral arterial disease and chronic lower-limb wounds face high rates of amputation due to poor blood circulation and complications from traditional external surgical frames.

Solution

BlueHealer develops an internal implantable orthopedic device for tibial transverse transport that stimulates blood flow to preserve limbs while avoiding the infection and fracture risks of external fixation.

Why now

Surging global rates of diabetic vascular complications combined with advances in minimally invasive internal orthopedic hardware have created strong clinical demand for safer limb-salvage solutions.

Source: SEC EDGAR Form D filing